QSER1 preserves the suppressive status of the pro-apoptotic genes to prevent apoptosis
Xiru Zhao1, Ke Fang1, Xiaoxu Liu1
1Key Laboratory of Developmental Genes and Human Disease, School of Life Science and Technology, Southeast University, Nanjing, 210096, China.
Abstract:
Activation of the pro-apoptotic genes by the p53 family is a critical step in induction of apoptosis. However, the molecular signaling underlying their suppression remains largely unknown. Here, we report a general role of QSER1 in preventing apoptosis. QSER1 is widely up-regulated in multiple cancers, and its up-regulation correlates with poor clinic outcomes. QSER1 knockdown significantly promotes apoptosis in both p53 wild type and mutant cancer cells. Interestingly, we show that QSER1 and p53 occupy distinct cis-regulatory regions in a common subset of the pro-apoptotic genes, and function antagonistically to maintain their proper expression. Furthermore, we identify a key regulatory DNA element named QSER1 binding site in PUMA (QBP). Deletion of QBP de-represses PUMA and induces apoptosis. Mechanistically, QSER1 functions together with SIN3A to suppress PUMA in a p53-dependent and -independent manner, suggesting that QSER1 inhibition might be a potential therapeutic strategy to induce apoptosis in cancers.
Insights
The study reveals that QSER1 prevents apoptosis by suppressing pro-apoptotic genes like PUMA. Inhibiting QSER1 promotes cancer cell death, suggesting it as a potential cancer therapy.
Area of Science:
- Molecular Biology
- Cancer Research
- Cell Death Signaling
Background:
- p53 family activation of pro-apoptotic genes is crucial for apoptosis induction.
- Molecular mechanisms regulating the suppression of pro-apoptotic genes are not well understood.
Purpose of the Study:
- To investigate the role of QSER1 in preventing apoptosis.
- To elucidate the molecular mechanisms by which QSER1 suppresses pro-apoptotic genes.
- To explore QSER1 as a potential therapeutic target in cancer.
Main Methods:
- QSER1 expression analysis in various cancers.
- QSER1 knockdown experiments in cancer cells (p53 wild type and mutant).
- Chromatin immunoprecipitation to identify QSER1 and p53 binding sites.
- Reporter assays and deletion analysis of the QSER1 binding site in PUMA (QBP).
Main Results:
- QSER1 is upregulated in multiple cancers, correlating with poor outcomes.
- QSER1 knockdown significantly induces apoptosis in cancer cells.
- QSER1 and p53 bind distinct regulatory regions of pro-apoptotic genes, acting antagonistically.
- Identification of QBP, a DNA element where QSER1 binds to suppress PUMA.
- Deletion of QBP leads to PUMA de-repression and apoptosis.
- QSER1, with SIN3A, suppresses PUMA in both p53-dependent and -independent pathways.
Conclusions:
- QSER1 plays a general role in preventing apoptosis by suppressing pro-apoptotic gene expression.
- QSER1 upregulation in cancer is linked to poor prognosis.
- Targeting QSER1 could be a viable therapeutic strategy to induce apoptosis in cancer treatment.
Related Concept Videos
Caspases
Apoptosis
The Extrinsic Apoptotic Pathway
Abnormal Proliferation
The Intrinsic Apoptotic Pathway
Negative Regulator Molecules


